Profil
Esther Welkowsky currently works at Elicio Therapeutics, Inc. (United States), as Vice President-Clinical Development from 2020 and Elicio Therapeutics, Inc., as Senior Vice President-Clinical Development.
Ms. Welkowsky also formerly worked at Allogene Therapeutics, Inc., as Executive Director-Clinical Operations from 2018 to 2020 and Atara Biotherapeutics, Inc., as Head-Clinical Operations.
Ms. Welkowsky received her undergraduate degree from the University of California, Santa Barbara.
Postes actifs de Esther Welkowsky
| Sociétés | Poste | Début |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Elicio Therapeutics, Inc. (United States)
Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Corporate Officer/Principal | 01/04/2020 |
Anciens postes connus de Esther Welkowsky
| Sociétés | Poste | Fin |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2020 |
| ATARA BIOTHERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Esther Welkowsky
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Elicio Therapeutics, Inc. (United States)
Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Health Technology |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Elicio Therapeutics, Inc.
Elicio Therapeutics, Inc. BiotechnologyHealth Technology Develops cancer immunotherapies | Health Technology |
















